KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss sending shares down 259 percent today RVSNW Rail signals focus on new North American rail client wins as its latest quarterly earnings metrics remain undisclosed Apple CEO Succession and AI Era Strategic Roadmap Analysis